Stock SEQUA SEQUANA MEDICAL N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sequana Medical N.V.

Equities

SEQUA

BE0974340722

Biotechnology & Medical Research

Market Closed - Euronext Bruxelles
Other stock markets
 10:57:13 2024-04-26 am EDT 		5-day change 1st Jan Change
1.39 EUR -0.71% Intraday chart for Sequana Medical N.V. -3.47% -65.25%
Apr. 03 Sequana Medical Announces Strong Data from DSR Proof-of-Concept Studies in Heart Failure Published in European Journal of Heart Failure CI
Mar. 28 Sequana Medical NV Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 78.95 186.2 140.4 142.5 113 49.91 - -
Enterprise Value (EV) 1 76.59 186.2 138.2 140.3 127.9 97.41 67.61 71.71
P/E ratio -5.13 x - -5.82 x -4.44 x -3.28 x -2.36 x -27.8 x -5.56 x
Yield - - - - - - - -
Capitalization / Revenue 81.3 x 193 x 379 x 154 x 159 x 76.8 x 1.59 x 2.19 x
EV / Revenue 78.9 x 193 x 372 x 152 x 180 x 150 x 2.15 x 3.15 x
EV / EBITDA -5.58 x -10.7 x -6.22 x -5.05 x -4.54 x -7.38 x 135 x -10.4 x
EV / FCF -4.07 x - - - -4.3 x -2.81 x - -
FCF Yield -24.6% - - - -23.3% -35.6% - -
Price to Book 85.8 x - - - - - - -
Nbr of stocks (in thousands) 12,612 15,779 18,577 23,747 28,243 35,909 - -
Reference price 2 6.260 11.80 7.560 6.000 4.000 1.390 1.390 1.390
Announcement Date 3/19/20 3/17/21 4/12/22 2/9/23 3/28/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 0.971 0.963 0.371 0.923 0.712 0.65 31.4 22.8
EBITDA 1 -13.72 -17.46 -22.2 -27.78 -28.2 -13.2 0.5 -6.9
EBIT 1 -13.96 - -22.61 -28.09 -28.86 -23.55 - -7.2
Operating Margin -1,438.11% - -6,095.42% -3,043.77% -4,053.65% -3,622.46% - -31.58%
Earnings before Tax (EBT) 1 -14.84 - -23.22 -30.38 -32.1 -23.25 - -
Net income 1 -14.98 - -23.62 -30.76 -32.56 -20.8 -1.1 -5.9
Net margin -1,542.43% - -6,365.23% -3,332.94% -4,573.6% -3,199.38% -3.5% -25.88%
EPS 2 -1.220 - -1.300 -1.350 -1.220 -0.5900 -0.0500 -0.2500
Free Cash Flow 1 -18.82 - - - -29.77 -34.7 - -
FCF margin -1,937.69% - - - -4,181.74% -5,338.46% - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 3/19/20 3/17/21 4/12/22 2/9/23 3/28/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q3 2023 S1 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - - 0.23 - 0.1 0.1 0.1 0.1
EBITDA - - - - - - - -
EBIT 1 -5.57 -5.57 -7.67 - -4.723 -4.723 -4.723 -4.723
Operating Margin - - -3,334.78% - -4,723% -4,723% -4,723% -4,723%
Earnings before Tax (EBT) 1 -5.73 -5.73 -7.89 - -5.623 -5.423 -5.523 -5.423
Net income 1 -5.86 -5.86 -7.95 -16.46 -5.623 -5.423 -5.523 -5.423
Net margin - - -3,456.52% - -5,623% -5,423% -5,523% -5,423%
EPS 2 -0.3200 -0.3200 -0.3300 -0.6500 -0.1800 -0.1500 -0.1400 -0.1300
Dividend per Share - - - - - - - -
Announcement Date 4/27/22 4/12/22 2/9/23 9/14/23 - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - 14.9 47.5 17.7 21.8
Net Cash position 1 2.36 - 2.28 2.2 - - - -
Leverage (Debt/EBITDA) - - - - -0.5296 x -3.598 x 35.4 x -3.159 x
Free Cash Flow 1 -18.8 - - - -29.8 -34.7 - -
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 0.0700 - - - - - - -
Cash Flow per Share 2 - - - - -1.090 -0.5900 -0.0200 -0.2300
Capex 1 0.33 - 0.33 0.68 0.71 0.15 - -
Capex / Sales 34.29% - 87.87% 73.35% 99.86% 23.08% - -
Announcement Date 3/19/20 3/17/21 4/12/22 2/9/23 3/28/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Sequana Medical N.V.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
1.39 EUR
Average target price
5.967 EUR
Spread / Average Target
+329.26%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
SEQUANA MEDICAL N.V. Stock Sequana Medical N.V.
-65.25% 53.29M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. SEQUA Stock
  4. Financials Sequana Medical N.V.